What AIRS does

AIRS is a South Korea–based deeptech medical device company that develops surgical robotics and AI-powered navigation systems for orthopaedic surgery, with an initial focus on long bone fracture reduction. Its RONAVIS product line comprises three integrated devices: RONAVIS-RD, a semi-autonomous surgical robot built on a Stewart platform with six degrees of freedom that executes pre-planned fracture reduction under surgeon supervision; RONAVIS-PN, a real-time navigation and guidance system that reconstructs 3D bone fragment models from 2D radiological images, plans reduction paths, and reduces intraoperative X-ray exposure by up to 90%; and RONAVIS-FX, a uni-cortical external fixation system using a screwless expanding wedge anchor for greater stability with reduced soft tissue damage.

The company sells its RONAVIS suite through direct enterprise sales to hospitals and orthopaedic surgery departments, with active sales in selected regions and regulatory submissions underway in additional key markets. Revenue is generated primarily through hardware sales of capital equipment and consumables, with potential future upside from technology licensing of its substantial IP portfolio. The company is targeting orthopaedic surgery departments, trauma and fracture care specialists, and minimally invasive surgery programs, while pursuing geographic expansion via clinical partnerships with Woodlands Health Campus (Singapore), Meir Medical Center (Israel), and Inova Fairfax Medical Campus (US).

AIRS was founded in 2020 by three academic medical and robotics leaders from Kyungpook National University — Prof Sanghyun Joung (CEO), Prof Il-Hyung Park (CMO), and Prof Chang-Wug Oh (Director) — who together hold over 120 patents and have authored more than 490 peer-reviewed publications. The company raised approximately $5.9 million in March 2025 from Korean institutional investors including L&S Venture Capital and Scaleup Tips, and is developing additional technologies including a Bone Endoscopic Robotic System for minimally invasive medullary procedures.

Name

AIRS

Legal name

AIRS Inc.

Website

https://airsurgical.net

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

AIRS is a South Korean deeptech company that develops surgical robotics and AI-powered navigation systems for orthopaedic fracture surgery. It sells the RONAVIS platform (robot, navigation, and fixation devices) directly to hospitals and orthopaedic surgery departments across selected international markets.

Ownership category

akta.pro rank

Product category

Orthopaedic Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

• Surgical robotics
• Orthopedic navigation systems
• Fracture reduction technology
• Medical robotics platforms
• External fixation devices

Headquarters

HQ city

Daegu

HQ country

South Korea

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Surgical Robot Sales: Sales of RONAVIS suite of products including surgical robots (RONAVIS-RD), navigation systems (RONAVIS-PN), and fixation devices (RONAVIS-FX). Sales are ongoing in selected regions with regulatory approval in progress for other markets.
2. Technology Licensing: The company is developing new medical technologies and adapting existing ones. Given the extensive patent portfolio (60+ patents for CEO, 18 international + 44 domestic for CMO), technology licensing may be a potential revenue stream for their orthopaedic surgical robotics IP.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

AIRS develops, manufactures, and sells the RONAVIS product line, an integrated suite of surgical robots and navigation devices for orthopaedic surgery, with an initial focus on long bone fracture reduction. The line comprises RONAVIS-RD (semi-autonomous surgical robot on a Stewart platform with 6 degrees of freedom), RONAVIS-PN (real-time 3D navigation and pathfinding system that reduces X-ray exposure by up to 90%), and RONAVIS-FX (uni-cortical external fixation system with a screwless expanding wedge anchor). The RONAVIS suite is sold to hospitals and orthopaedic surgery departments through direct enterprise sales, with regulatory approvals being obtained in additional markets.

Product overview

AIRS offers a unified product line called RONAVIS focused on orthopaedic surgery, comprising three interconnected surgical devices: RONAVIS-RD (semi-autonomous surgical robot for long bone fracture reduction), RONAVIS-PN (real-time navigation and guidance system for fracture reduction), and RONAVIS-FX (uni-cortical external fixation system). These products are designed to work together to enable Surgery 4.0 through intelligent navigation, data integration, and precision robotics for greater efficiency and better patient outcomes in orthopaedics.

Differentiator

Problem solved

Functional benefit

Brands

• RONAVIS: Line of surgical devices for orthopaedics, including RONAVIS-RD (semi-autonomous surgical robot for long bone fracture reduction), RONAVIS-PN (real-time navigation and guidance system for fracture reduction surgery), and RONAVIS-FX (uni-cortical external fixation system).

Products and services

• RONAVIS-RD Semi-autonomous surgical robot for long bone fracture reduction, built on a Stewart platform with 6 degrees of freedom. It performs fracture reduction according to pre-planned reduction paths chosen by the surgical team and features a detachable actuator designed for sterilization and surgical draping. It targets orthopaedic surgeons and hospitals performing fracture reduction procedures, enabling faster procedures with better outcomes while reducing required manpower.
• RONAVIS-PN Real-time navigation and guidance system for fracture reduction surgery that generates 3D models from 2D radiological images, enables real-time monitoring of bone fragment positions, plans optimized reduction paths, and reduces X-ray exposures by up to 90%. It is designed for orthopaedic surgical teams performing fracture reduction procedures and trauma surgery.
• RONAVIS-FX Uni-cortical external fixation system featuring an innovative screwless design with an expanding wedge anchor that compresses against bone for a stable interface. It outperforms existing solutions under compression and torsion loads and is designed for trauma surgeons and fracture care specialists requiring advanced fixation with greater stability and reduced soft tissue damage.

Quantifiable outcome

• Up to 90% fewer X-rays required during fracture reduction procedures with RONAVIS-PN
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Woodlands Health CampuscoreStrategic or Co-development PartnerHealthcare institution partnership providing clinical validation and collaboration in surgical robotics development and testing.
• Meir Medical CentercoreStrategic or Co-development PartnerMedical center partnership for clinical collaboration and validation of AIRS surgical robotics technology.
• Inova Fairfax Medical CampuscoreStrategic or Co-development PartnerMajor US medical campus partnership for clinical validation and market presence in North America.
• Fairfax County Economic Development AuthorityminorStrategic or Co-development PartnerEconomic development partnership supporting market entry and expansion in the Fairfax County region.
• Century MedicalminorStrategic or Co-development PartnerMedical technology partnership for distribution or integration of surgical solutions.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ortho Development Corporation: Ortho Development designs and manufactures orthopedic trauma and extremity implants and fixation devices. Comparable to AIRS for the RONAVIS-FX external fixation product, addressing the same orthopedic trauma and fracture-care market.
• THINK Surgical: THINK Surgical develops computer-assisted robotic systems specifically for orthopedic surgery, including TMINI and TSolution One platforms. It is the closest direct competitor to AIRS in orthopedic surgical robotics with a similar niche-focused commercialization model.

Broad incumbents

• Brainlab: Brainlab offers surgical navigation, planning, and augmented-reality platforms used widely in orthopedic and neurosurgery. Its intraoperative navigation and imaging software overlaps directly with AIRS's RONAVIS-PN navigation system.
• Intuitive Surgical (da Vinci): Intuitive Surgical is the global leader in surgical robotics with da Vinci systems installed across thousands of hospitals. While focused on soft-tissue procedures, its dominance and installed-base dynamics set the competitive benchmark for any surgical robotics company seeking hospital adoption.
• Stryker (Mako Surgical): Stryker's Mako platform is the dominant orthopedic surgical robotics system for joint replacement, with broad hospital penetration and substantially greater R&D resources. It is the most relevant incumbent AIRS would compete against or partner with as Mako expands into trauma indications.
• Renishaw (Neuromate / orthopedic navigation): Renishaw produces surgical navigation and robotic systems including neuromate and orthopedic applications, with strong engineering IP and global distribution. Comparable to AIRS as a precision surgical navigation and robotics vendor targeting hospital specialty departments.
• Smith+Nephew (CORI Surgical Robotics): Smith+Nephew's CORI handheld robotics system targets orthopedic procedures including knee arthroplasty, with a global commercial footprint. It is directly comparable to AIRS as another orthopedic-focused robotics entrant pursuing hospital capital sales.

Emerging players

• Moon Surgical: Moon Surgical is an emerging surgical robotics company developing a compact, AI-assisted robotic assistant for the operating room. Comparable to AIRS as a well-funded European robotics startup pursuing a similar hospital-surgical-assistant positioning.
• Medivis: Medivis builds AI-driven surgical visualization and holographic navigation for operating rooms. Comparable to AIRS as an early-stage company augmenting surgical navigation with computer vision, targeting similar orthopedic and trauma workflows.
• Activ Surgical: Activ Surgical develops AI-powered surgical intelligence and visualization tools for intraoperative decision support. Comparable to AIRS as a digital surgery platform applying computer vision and AI to surgical workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ai-robot-surgery

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIRS